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Abstract
Background:  Visceral obesity is positively related to insulin resistance. The nature of the
relationship between waist circumference and insulin resistance has not been known in Japanese
populations. This study examined the relationship between waist circumference and insulin
resistance and evaluated the optimal cutoff point for waist circumference in relation to insulin
resistance in middle-aged Japanese men.
Methods: Study subjects included 4800 Japanese men aged 39 to 60 years. Insulin resistance was
evaluated by the homeostasis model assessment of insulin resistance (HOMA-IR). The relationship
of waist circumference with HOMA-IR was assessed by use of adjusted means of HOMA-IR and
odds ratios of elevated HOMA-IR defined as the highest quintile (≥2.00). Receiver operating
characteristics (ROC) curve analysis using Youden index and the area under curve (AUC) was
employed to determine optimal cutoffs of waist circumference in relation to HOMA-IR.
Results: Adjusted geometric means of HOMA-IR and prevalence odds of elevated HOMA-IR were
progressively higher with increasing levels of waist circumference. In the ROC curve analysis, the
highest value of Youden index was obtained for a cutoff point of 85 cm in waist circumference
across different values of HOMA-IR. Multiple logistic regression analysis also indicated that the
AUC was consistently the largest for a waist circumference of 85 cm.
Conclusion: Waist circumference is linearly related to insulin resistance, and 85 cm in waist
circumference is an optimal cutoff in predicting insulin resistance in middle-aged Japanese men.
Background
Visceral obesity is closely linked to insulin resistance, and
is currently regarded as a principle component of the met-
abolic syndrome [1,2]. It is well documented that insulin
resistance is predictive of the risk of type 2 diabetes and
cardiovascular disease [3-6]. In conjunction with world-
wide recognition of the metabolic syndrome [2], the size
of waist circumference as an estimate of visceral obesity
has been a matter of controversy. The International Diabe-
tes Federation (IDF) has adopted different cutoffs for
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waist circumference in different ethnicities [7]; the cutoff
points for Europids are 94 cm in men and 80 cm in
women while those for Chinese and South Asians are 90
in men and 80 in women. The cutoff points for Japanese
are set at 85 cm in men and 90 cm in women [7]. These
cutoffs for Japanese were derived from the criteria for the
metabolic syndrome proposed by an expert group of
obesity research in Japan [8]. This recommendation was
based on the findings from a cross-sectional study of 1200
men and women that waist circumferences corresponding
to 100 cm2 of visceral fat area were 84.4 cm in men and
92.5 cm in women [8]. The visceral fat area of 100 cm2
obtained from computed tomography was postulated as a
threshold of the accumulation of obesity-related diseases
[8]. Several cross-sectional studies have evaluated appro-
priateness of the cutoffs proposed for Japanese, showing
optimal cutoffs of 85–87 cm for men and 80–82 cm for
women [9-11]. However, these studies [9-11] as well as
the original study [8] were primarily based on the rela-
tionship between waist circumference and multiple com-
ponents other than abdominal obesity of the metabolic
syndrome. These definitions have not been directly exam-
ined in relation to type 2 diabetes or insulin resistance.
Furthermore, the nature of the relationship between waist
circumference and insulin resistance or hyperinsulinemia
has not been examined in Japanese populations. We
examined the relationship between waist circumference
and insulin resistance in a large population of middle-
a g e d  J a p a n e s e  m e n .  I n  t h i s  s t u d y ,  w e  a i m  t o  c l a r i f y
whether there is a threshold in waist circumference in rela-
tion to insulin resistance and whether the proposed cutoff
of waist circumference for Japanese men is appropriate.
Methods
Study subjects
Study subjects were male officials in the Self-Defense
Forces (SDF) who received a pre-retirement health exami-
nation from January 1997 to March 2002, health check-
up at age 50 years from April 2002 to September 2006, or
health check-up at age 40 years from April 2005 to Sep-
tember 2006 at the Self-Defense Force Fukuoka Hospital.
The pre-retirement health examination was a nationwide
program offering a comprehensive medical examination
to those retiring from the SDF. The health check-ups at age
40 and 50 years are also a nationwide program, including
almost the same items of examinations as done in the pre-
retirement health examination. The health check-up at age
50 years was substituted for the pre-retirement health
examination in April 2002, and the health check-up at age
40 years was newly introduced in April 2005. These health
examinations included abdominal ultrasonography, 75-g
oral glucose tolerance test and blood biochemistry among
others, as described in detail elsewhere [12,13]. The study
was approved by the ethics committee of Kyushu Univer-
sity Faculty of Medical Sciences.
In a consecutive series of 5423 men during the above-
mentioned period, 301 men refused to participate in the
survey. Excluded were those with morbid conditions
affecting glucose metabolism or insulin levels. Thus, of
the remaining 5122 men, 200 were excluded because of a
prior history of cancer (n = 61), newly diagnosed cancer (n
= 12), prevalent conditions such as thyroid disease (n =
20), chronic hepatitis or liver cirrhosis (n  = 71), and
chronic kidney disease (n = 14), use of steroids (n = 17) or
insulin (n = 20); some men had more than one condition
for exclusion. We also excluded 122 men in whom fasting
plasma insulin or glucose was not determined (n = 121)
and waist circumference was not measured (n = 1). A total
of 4800 men remained in the analysis. We did not exclude
individuals with oral medication for diabetes mellitus so
as to maximize the number of subjects with insulin resist-
ance in the analysis. Insulin resistance status is probably
not affected measurably by oral medication for diabetes
mellitus [14].
Procedures
Venous blood was sampled after an overnight fast for bio-
chemical measurements. Plasma glucose and insulin were
determined by the glucose oxidase method and the
enzyme immunoassay, respectively, using commercial
kits at the hospital laboratory. Assay kits were obtained
from different sources during the period, but standardiza-
tion was done routinely on the introduction of new assay
kits. Insulin resistance was evaluated by the homeostasis
model assessment of insulin resistance (HOMA-IR) [15].
This measure reportedly explains 65% of insulin sensitiv-
ity measured by the glucose clamp technique [16]. Waist
circumference was measured in the horizontal plane at
the umbilical level by nurses with a subject wearing
underwear in a standing position.
A self-administered questionnaire was used to ascertain
alcohol use, smoking habits, and other lifestyle character-
istics. Details of the questionnaire have been described
previously [12,13]. In brief, smokers were defined as those
who had ever smoked cigarettes daily for at least one year.
Former smokers were separated from lifelong nonsmok-
ers, and current and past smokers reported the average
number of cigarettes smoked per day. Cigarette smoking
was classified into five categories (never, past, and current
with a consumption of < 20, 20–24, or ≥ 25 cigarettes per
day). Alcohol drinkers were defined as those having drunk
alcoholic beverages at least once per week for one year or
longer, and former alcohol use was separated from life-
time non-use of alcohol. Daily ethanol intake was esti-
mated for current drinkers on the basis of consumption
frequencies and amounts of five types of alcoholic bever-BMC Endocrine Disorders 2009, 9:1 http://www.biomedcentral.com/1472-6823/9/1
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ages (sake, shochu, beer, whisky/brandy and wine) on
average in the past year. Alcohol use was categorized into
never, past, and current with a consumption of < 30, 30–
59, or ≥ 60 ml of ethanol per day. Medical history and cur-
rent medication were ascertained by ward nurses and phy-
sicians.
Statistical analysis
The relationship of waist circumference with HOMA-IR
was statistically assessed by use of adjusted means of
HOMA-IR and odds ratios of elevated HOMA-IR arbitrar-
ily defined as the highest quintile (≥2.00). The adjusted
means were calculated by analysis of covariance, and the
odds ratios with 95% confidence intervals were obtained
by the logistic regression analysis. The distribution of
HOMA-IR was skewed to the right side, and the values
were transformed to the natural logarithms in the analy-
sis. Thus the presented means were always geometric
means. Statistical adjustment was made for age, rank in
the SDF (three classes), smoking, and alcohol use. Trend
of the association was assessed with ordinal scores
assigned to the levels of waist circumference.
Receiver operating characteristics (ROC) curve analysis
was employed to determine optimal cutoffs of waist cir-
cumference in relation to insulin resistance defined by dif-
ferent values of HOMA-IR, with and without allowance
for the covariates. In the analysis without consideration to
the covariates, the optimal cutoff point was obtained by
the Youden index, i.e., maximum (sensitivity + specificity
-1) [17]. After logistic regression analysis controlling for
the covariates, ROC curve was depicted and area under
ROC curve (AUC) was calculated for each of the cutoffs of
80, 85, and 90 cm in waist circumference. Statistical sig-
nificance was declared if a two-sided P value was less than
0.05 or if the 95% confidence intervals did not include
unity. All computations were mostly performed using the
SAS version 8.2 (SAS Institute Inc., Cary, NC). The ROC
curve analysis was done by using Stata SE version 8 (Stata,
College Station, TX).
Results
Age ranged 39 to 60 years, with a mean of 51. Character-
istics of the study subjects are described in Table 1. Spear-
man correlation coefficient between waist circumference
and HOMA-IR was 0.52. As shown in Figure 1, geometric
means of HOMA-IR were progressively higher with
increasing levels of waist circumference; age-adjusted
means for the waist circumference of < 80, 80–84, 85–89,
90–94, and ≥ 95 were 0.76, 1.07, 1.42, 1.73, and 2.49
(trend P < 0.0001). Adjustment for rank in the SDF, smok-
ing, and alcohol use did not change the relation; adjusted
geometric means from the lowest to highest categories of
waist circumference were 0.76, 1.08, 1.42, 1.74, and 2.46,
respectively (trend P < 0.0001).
The prevalence odds of elevated HOMA-IR (≥ 2.00) also
increased stepwise with increasing circumferences of the
waist (Table 2). Men with a waist of 80–84 cm showed a
statistically significant increase in the odds ratio as com-
pared with the lowest category of waist circumference (<
80 cm). Waist circumference of 90–94 was associated with
a 15-fold increase in the odds ratio of elevated HOMA-IR,
and a 45-fold increase in the odds ratio was noted for the
highest category (≥ 95 cm).
In the ROC curve analysis (Table 3), the highest value of
Youden index was obtained for a cutoff point of 85 cm in
waist circumference across different values of HOMA-IR.
The multiple logistic regression analysis also indicated
that the AUC was consistently the largest for a waist cir-
cumference of 85 cm (Figure 2).
Discussion
The present study demonstrated a strong, linear relation-
ship between waist circumference and insulin resistance
as expressed by HOMA-IR in a large population of Japa-
nese men. Both geometric means and prevalence odds of
elevated HOMA-IR were progressively greater in propor-
tion to the size of waist circumference. The increase was
evident even in men with the average size of waist, i.e.,
80–84 cm. It was also found that 85 cm of waist circum-
ference was an optimal cutoff for predicting insulin resist-
ance. The finding adds to evidence for optimality of the
cutoff for waist circumference proposed for Japanese men.
Obesity has been known to be positively related to insulin
resistance. Increased secretion of free fatty acids, inflam-
Table 1: Characteristics of the study subjects
Variable Value
Age (year), mean (SD) 50.5 (3.7)
Body mass index (kg/m2), mean (SD) 24.0 (2.7)
Waist circumference (cm), mean (SD) 83.7 (7.2)
Current smoking (%) 48.2
Alcohol use (%) 66.1
Physical activity (MET-hours/week)*, median (IQR) 16 (5–27)
Serum total cholesterol (mg/dL), mean (SD) 206.7 (34.5)
Serum HDL cholesterol (mg/dL), mean (SD) 57.2 (16.4)
Serum triglycerides (mg/dL), median (IQR) 127 (91–178)
Fasting plasma glucose (mmol/L), median (IQR) 5.6 (5.2–6.0)
Fasting plasma insulin (pmol/L), median (IQR) 34 (22–50)
HOMA-IR, median (IQR) 1.18 (0.77–1.80)
History of myocardial infarction (%) 0.5
History of stroke (%) 0.9
Use of lipid-lowering drug (%) 3.1
Use of antihypertensive drug (%) 9.9
Oral medication for diabetes mellitus (%) 1.3
* Leisure-time physical activity.
IQR, interquartile range; HOMA-IR, homeostasis model assessment 
of insulin resistance; MET, metabolic equivalent.BMC Endocrine Disorders 2009, 9:1 http://www.biomedcentral.com/1472-6823/9/1
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matory cytokines and decreased secretion of adiponectin
are molecules mediating obesity and insulin resistance
[18,19]. Few studies have directly addressed the relation-
ship between waist circumference and insulin resistance
or hyperinsulinemia [20,21]. A small cross-sectional
study reported a linear increase in the prevalence of hyper-
insulinemia across the deciles of waist circumference in
185 healthy men in Canada [20]. In a cross-sectional
study of 2746 volunteers aged 18–72 years, including 798
men, waist circumference was strongly correlated with
HOMA-IR [21]. The present study was the ever largest
study of men examining the relation between waist cir-
cumference and HOMA-IR. It is also notable that even
waist circumference of 80–84 cm was associated with an
evident increase in the prevalence odds of insulin resist-
ance. The finding is in agreement with the notion that
obesity-related risk is present at much lower levels of
obesity in Asians as compared with Caucasians [22].
Age-adjusted geometric means of HOMA-IR according to categories of waist circumference Figure 1
Age-adjusted geometric means of HOMA-IR according to categories of waist circumference. HOMA-IR, homeos-
tasis model assessment of insulin resistance.
Table 2: Age-adjusted and multivariate-adjusted odds ratios of elevated HOMA-IR according to categories of waist circumference
Number of men (%) Odds ratio (95% confidence interval)
Waist (cm) Total Elevated HOMA-IR* Age-adjusted Multivariate-adjusted†
< 80 1375 58 (4.2) 1.0 (referent) 1.0 (referent)
80–84 1307 156 (11.9) 3.0 (2.2–4.2) 3.2 (2.3–4.3)
85–89 1141 296 (25.9) 7.8 (5.8–10.5) 8.2 (6.1–11.0)
90–94 645 247 (38.3) 13.9 (10.3–19.0) 15.2 (11.1–20.8)
95+ 332 216 (65.1) 42.2 (29.8–59.7) 45.2 (31.8–64.4)
* The top quintile of HOMA-IR (≥ 2.00).
† Adjusted for age, rank in the Self-Defense Forces, smoking, and alcohol use.
HOMA-IR, homeostasis model assessment of insulin resistance.BMC Endocrine Disorders 2009, 9:1 http://www.biomedcentral.com/1472-6823/9/1
Page 5 of 7
(page number not for citation purposes)
Insulin resistance is an obesity-related condition preced-
ing the development of impaired glucose tolerance and
type 2 diabetes. Insulin resistance, through suppression of
glucose uptake in skeletal muscle and increase in hepatic
glucose production, causes hyperglycemia [1]. Insulin
resistance expressed by HOMA-IR is well in agreement
with that evaluated directly by the euglycemic clamp
method [15,16], and is generally accepted as a valid
method in epidemiological surveys [23]. However, there
is no clear cutoff for the definition of insulin resistance
based on HOMA-IR. Insulin resistance based on HOMA-
IR has been defined differently in different studies. For
instance, insulin resistance was defined as HOMA-IR of ≥
3.80, which corresponded to the 90th percentile in
healthy subjects, in Spain [24], and a value of 4.00 or
greater was used in a Swedish study [21]. HOMA-IR ≥ 1.73
was used in a Japanese study [25]. We defined insulin
resistance arbitrarily as HOMA-IR greater than the 80th
percentile (≥ 2.00) in examining the relationship with
waist circumference. Repeated analyses using HOMA-IR
cutoffs of 1.50 and 2.50 showed almost the same results
in terms of the prevalence odds (data not shown). Differ-
ent values of HOMA-IR were used in the ROC curve anal-
ysis of searching for an optimal cutoff for waist
circumference. It should be noted that the optimal cutoff
point was consistently 85 cm for any values of HOMA-IR.
However, the discordance between abdominal obesity (≥
85 cm) and insulin resistance accounted for no less than
33%. This value was almost equal to or slightly greater
than those reported for the discordance between meta-
bolic syndrome and insulin resistance among Americans
and Turks [26]. Thus, although waist circumference was
Table 3: Optimal cutoffs of waist circumference in different HOMA-IR values from ROC curve analysis
HOMA-IR Prevalence (%) Cutoff of WC (cm) Sensitivity (%) Specificity (%) Youden index
1.50 34.9 80 91.5 39.5 0.310
85 70.4 70.0 0.403
90 38.8 89.5 0.284
2.00 20.3 80 94.0 34.4 0.285
85 78.0 64.5 0.425
90 47.6 86.6 0.342
2.50 12.0 80 96.0 32.0 0.280
85 83.8 61.3 0.451
90 56.1 84.5 0.406
3.00 7.8 80 96.3 30.7 0.270
85 85.3 59.3 0.446
90 60.1 83.0 0.430
ROC, receiver operating characteristics; HOMA-IR, homeostasis model assessment of insulin resistance; WC, waist circumference.
ROC curves for different waist circumferences in relation to insulin resistance Figure 2
ROC curves for different waist circumferences in relation to insulin resistance. panel A: HOMA-IR ≥ 1.50; panel B: 
HOMA-IR ≥ 2.00; and panel C: HOMA-IR ≥ 2.50. ROC curves are shown for waist circumferences of 80 cm (blue line), 85 cm 
(red line), and 90 cm (green line). Logistic regression analysis was used with adjustment for age, rank in the Self-Defense 
Forces, smoking, and alcohol use. ROC, receiver operating characteristics; HOMA-IR, homeostasis model assessment of insu-
lin resistance.BMC Endocrine Disorders 2009, 9:1 http://www.biomedcentral.com/1472-6823/9/1
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found to be strongly related to insulin resistance, it is
unlikely that Japanese men have less confounders in the
relationship under study as compared with other ethnici-
ties.
More emphasis has been placed on waist circumference as
an estimate of visceral adiposity rather than body mass
index in the prevention of obesity-related diseases. In the
present study population, waist circumference and body
mass index were highly correlated with each other (Pear-
son correlation coefficient 0.86), and body mass index
was as strongly associated with HOMA-IR as waist circum-
ference. For example, an increase of one SD in body mass
index was associated with an 42.0% increase in HOMA-IR
while the corresponding value for waist circumference
was 43.7%.
A strength of the present study was that the study popula-
tion was very large and relatively homogeneous in terms
of the social background. There were several weaknesses
to be discussed. The present study was based on estimated
measures for both visceral adiposity and insulin resist-
ance, and these estimates necessarily suffered some inac-
curacy which may have attenuated the association
between the two. Interpretation of causality is difficult in
cross-sectional studies. It is possible that insulin resistance
or related conditions may increase visceral adiposity. Fur-
thermore, inflammation and atherosclerosis are linked to
insulin resistance, and these conditions may confound
the relationship under study. Our study subjects were not
representative of middle-aged Japanese men. Age was lim-
ited to a small range, and the subjects were those who had
remained in the SDF until the age of 50 years on average.
It is possible that the study subjects differed from the gen-
eral population with respect to both waist circumference
and insulin resistance, although body mass index in the
study population did not differ from that of the general
population. In the National Nutrition Survey in 2000,
means of body mass index for men aged 40s and 50s were
23.5 and 23.6, respectively [27]. It is also a limitation that
the study did not include women. Women, particularly
middle-aged ones, are very few in the SDF. Finally, it may
be argued that inclusion of men with oral medication for
diabetes may have distorted the association between waist
circumference and HOMA-IR. However, such men still
had higher values of HOMA-IR as compared with the oth-
ers (geometric means 2.02 versus 1.17).
Conclusion
A large cross-sectional study of Japanese men showed a
strong, linear relationship between waist circumference
and insulin resistance. The ROC curve analysis consist-
ently indicated that an optimal cutoff of waist circumfer-
ence was 85 cm in association with insulin resistance. The
findings lend a strong support for the Japanese criterion
for abdominal obesity in men in the metabolic syndrome.
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